Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2019

Aug 6, 2019

31971_dirs_2019-08-06_43783b14-f1c4-4b68-9737-1134ce2ab8f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-08-02

Reporting Person: Pelletier Johonna Marie (Treasurer and VP, Tax)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-08-02 Common Stock M 2000 $51.30 Acquired 5665 Direct
2019-08-02 Common Stock F 1547 $92.38 Disposed 4118 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-08-02 Sars (Stock Appreciation Rights) $51.30 M 2000 Disposed 2025-02-27 Common Stock (2000) Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.